Invivo antioxidant status: a putative target of antidepressant action
- PMID: 19059298
- DOI: 10.1016/j.pnpbp.2008.11.010
Invivo antioxidant status: a putative target of antidepressant action
Abstract
Oxidative stress is a critical route of damage in various psychological stress-induced disorders, such as depression. Antidepressants are widely prescribed to treat these conditions; however, few animal studies have investigated the effect of these drugs on endogenous antioxidant status in the brain. The present study employed a 21-day chronic regimen of random exposure to restraint stress to induce oxidative stress in brain, and behavioural aberrations, in rodents. The forced swimming (FST) and sucrose preference tests were used to identify depression-like phenotypes, and reversal in these indices indicated the effectiveness of treatment with fluoxetine (FLU; 20 mg/kg/day, p.o.; selective serotonin reuptake inhibitor), imipramine (IMI; 10 mg/kg/day, p.o.; tricyclic antidepressant) and venlafaxine (VEN; 10 mg/kg/day, p.o.; dual serotonin/norepinephrine reuptake inhibitor) following restraint stress. The antioxidant status was investigated in the brain of these animals. The results evidenced a significant recovery in the activities of superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione reductase (GR) and glutathione (GSH) levels by antidepressant treatments following a restraint stress-induced decline of these parameters. The severely accumulated lipid peroxidation product malondialdehyde (MDA) and protein carbonyl contents in stressed animals were significantly normalized by antidepressant treatments. The altered oxidative status is implicated in various aspects of cellular function affecting the brain. Thus, it is possible that augmentation of in vivo antioxidant defenses could serve as a convergence point for multiple classes of antidepressants as an important mechanism underlying the neuroprotective pharmacological effects of these drugs observed clinically in the treatment of various stress disorders. Consequently, pharmacological modulation of stress-induced oxidative damage as a possible stress-management approach should be an important avenue of further research.
Similar articles
-
Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats.Stress. 2009 Mar;12(2):167-77. doi: 10.1080/10253890802234168. Stress. 2009. PMID: 18850490
-
Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice.Pharmacol Biochem Behav. 2011 Nov;100(1):59-65. doi: 10.1016/j.pbb.2011.07.015. Epub 2011 Jul 29. Pharmacol Biochem Behav. 2011. PMID: 21835191
-
Restraint stress-induced oxidative damage and its amelioration with selenium.Eur J Pharmacol. 2008 Dec 14;600(1-3):59-63. doi: 10.1016/j.ejphar.2008.09.029. Epub 2008 Sep 30. Eur J Pharmacol. 2008. PMID: 18854182
-
The role of CREB in depression and antidepressant treatment.Biol Psychiatry. 2006 Jun 15;59(12):1144-50. doi: 10.1016/j.biopsych.2005.11.003. Epub 2006 Feb 2. Biol Psychiatry. 2006. PMID: 16457782 Review.
-
Sex differences in animal models of depression and antidepressant response.Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):226-33. doi: 10.1111/j.1742-7843.2009.00516.x. Epub 2009 Dec 30. Basic Clin Pharmacol Toxicol. 2010. PMID: 20050844 Review.
Cited by
-
Antidepressant-Like and Antioxidant Effects of Plinia trunciflora in Mice.Evid Based Complement Alternat Med. 2015;2015:601503. doi: 10.1155/2015/601503. Epub 2015 Jul 2. Evid Based Complement Alternat Med. 2015. PMID: 26229543 Free PMC article.
-
Attenuation of acute restraint stress-induced depressive like behavior and hippocampal alterations with protocatechuic acid treatment in mice.Metab Brain Dis. 2017 Apr;32(2):401-413. doi: 10.1007/s11011-016-9922-y. Epub 2016 Oct 26. Metab Brain Dis. 2017. PMID: 27785705
-
Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat.Metab Brain Dis. 2010 Jun;25(2):125-33. doi: 10.1007/s11011-010-9189-7. Epub 2010 May 9. Metab Brain Dis. 2010. PMID: 20455016
-
Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment.Curr Neuropharmacol. 2014 Mar;12(2):108-19. doi: 10.2174/1570159X11666131120231448. Curr Neuropharmacol. 2014. PMID: 24669206 Free PMC article.
-
Antidepressant fluoxetine and its potential against colon tumors.World J Gastrointest Oncol. 2014 Jan 15;6(1):11-21. doi: 10.4251/wjgo.v6.i1.11. World J Gastrointest Oncol. 2014. PMID: 24578784 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous